Oxidized Lipoproteins in Neurodegeneration
Oxidized Lipoproteins in Neurodegeneration
批准号:
6692892
负责人:
MARK S. KINDY
金额:
$29.2万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-08-15 至 2005-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This proposal tests the hypothesis that
oxidized lipoproteins induce neurodegeneration directly by acting on neurons
and indirectly by activating microglia through a mechanism involving scavenger
receptors. Oxidative stress mediated neuronal cell loss has been demonstrated
in neurodegenerative disorders including Alzheimer's disease (AD) and stroke.
Reactive oxygen species (ROS) can increase the rapid oxidation of lipids and
proteins generating lipid peroxidation and oxidized protein products. Once
formed, these oxidatively modified lipids and proteins may be the primary means
by which ROS toxicity is elicited. High-density lipoproteins (HDLs) in the
central nervous system are vulnerable to oxidative modification by trace
metals, ROS, and enzymatic pathways. Preliminary data demonstrate the
detrimental effects of oxidized HDL (oxHDL) on neuronal cells and the
activation of microglial response in vitro. The specific aims of this proposal
are: 1) To test the hypothesis that HDL induces neurodegeneration both in vitro
and in vivo by activating ROS. We will characterize the neuronal and microglial
response to oxHDL by activating oxidative stress, calcium and apoptotic
pathways. 2) To test the hypothesis that oxHDL functions through interaction
with scavenger receptors on neuronal and microglial cells. We will examine cell
lines expressing scavenger receptors (SR) and cells isolated from
SRgene-inactivation mice for altered response to oxHDL. 3) To test the
hypothesis that the apolipoprotein E (apoE) genotype may affect the level of
oxidation and the neuronal and microglial response to oxHDL. We will isolate
apoE-specific HDL particles and determine their susceptibility to oxidation and
their effects on neurodegeneration. 4) To test the hypothesis that oxidized HDL
and scavenger receptors are present in AD brain in a regional pattern related
to selective vulnerability. We will examine HDL isolated from control and AD
brain for oxidative status and the relationship to apoE genotype. We will also
examine the expression of SR and other molecules potentially relevant to the
effects of oxHDL in the AD brain. These studies should provide insights into
the normal function of HDL and SR in the CNS and in the pathogenesis of AD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BLRD Research Career Scientist Award Application
-
批准号:10451498
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:MARK S. KINDY
-
依托单位:
BLRD Research Career Scientist Award Application
-
批准号:10618300
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2020
-
负责人:MARK S. KINDY
-
依托单位:
ShEEP Request for 4D Bioprinting-Biofabrication of stimuli-responsive materials
-
批准号:9795834
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:MARK S. KINDY
-
依托单位:
ShEEP Request for CLARITY Optimized Light sheet Microscope for high speed imaging of large clarified samples at high resolution
-
批准号:9363118
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:MARK S. KINDY
-
依托单位:
Targeted Delivery of Antioxidant Drugs Following Cerebral Ischemic Injury
-
批准号:9040017
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:MARK S. KINDY
-
依托单位:
Targeted Delivery of Antioxidant Drugs Following Cerebral Ischemic Injury
-
批准号:9812773
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:MARK S. KINDY
-
依托单位:
Targeted Delivery of Antioxidant Drugs Following Cerebral Ischemic Injury
-
批准号:9398913
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:MARK S. KINDY
-
依托单位:
Complement and Traumatic Brain Injury
-
批准号:8857423
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:MARK S. KINDY
-
依托单位:
Complement and Traumatic Brain Injury
-
批准号:8856558
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:MARK S. KINDY
-
依托单位:
Complement and Traumatic Brain Injury
-
批准号:7870812
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:MARK S. KINDY
-
依托单位:
Complement and Traumatic Brain Injury
-
批准号:8466798
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:MARK S. KINDY
-
依托单位:
Pesticides, Paraoxonase and Alzheimer's Disease
-
批准号:7679342
-
项目类别:
-
资助金额:$40.56万
-
财政年份:2009
-
负责人:MARK S. KINDY
-
依托单位:
SC COBRE: ANIMAL PATHOBIOLOGY CORE
-
批准号:7959963
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2009
-
负责人:MARK S. KINDY
-
依托单位:
SC COBRE: ANIMAL PATHOBIOLOGY CORE
-
批准号:7720844
-
项目类别:
-
资助金额:$21.46万
-
财政年份:2008
-
负责人:MARK S. KINDY
-
依托单位:
Neprilysin and Abeta-degradation in Alzheimer's disease
-
批准号:6621395
-
项目类别:
-
资助金额:$23.71万
-
财政年份:2002
-
负责人:MARK S. KINDY
-
依托单位:
Neprilysin and Abeta-degradation in Alzheimer's disease
-
批准号:6434141
-
项目类别:
-
资助金额:$26.93万
-
财政年份:2002
-
负责人:MARK S. KINDY
-
依托单位:
Neprilysin and Abeta-degradation in Alzheimer's disease
-
批准号:6823227
-
项目类别:
-
资助金额:$22.56万
-
财政年份:2002
-
负责人:MARK S. KINDY
-
依托单位:
Neprilysin and Abeta-degradation in Alzheimer's disease
-
批准号:6719000
-
项目类别:
-
资助金额:$22.56万
-
财政年份:2002
-
负责人:MARK S. KINDY
-
依托单位:
Oxidized Lipoproteins in Neurodegeneration
-
批准号:6695869
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2001
-
负责人:MARK S. KINDY
-
依托单位:
Oxidized Lipoproteins in Neurodegeneration
-
批准号:6383291
-
项目类别:
-
资助金额:$28.96万
-
财政年份:2001
-
负责人:MARK S. KINDY
-
依托单位:
海外基金